Ovation Science Inc. (0VH.F)
| Previous Close | 0.0300 |
| Open | 0.0290 |
| Bid | 0.0260 x N/A |
| Ask | 0.0455 x N/A |
| Day's Range | 0.0260 - 0.0290 |
| 52 Week Range | 0.0005 - 0.0335 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | 1.103M |
| Beta (5Y Monthly) | 0.12 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0200 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ACCESSWIREOvation Science Expands Market Reach with Exclusive Canadian License Agreement
VANCOUVER, BC and LAS VEGAS, NV / ACCESSWIRE / April 11, 2024 / (CSE:OVAT)(OTCQB:OVATF) - Ovation Science Inc. ("Ovation" or the "Company"), with its patented topical and transdermal cannabis products powered by its skin delivery technology Invisicare®, ...
PR NewswireOvation Science Announces License Agreement for Its Topical / Transdermal Cannabis Products for Missouri
(CSE: OVAT) (OTCQB: OVATF) – Ovation Science USA Inc. ("Ovation" or the "Company"), with its proprietary topical and transdermal cannabis products powered by its patented skin delivery technology Invisicare®, today announced the signing of an exclusive licensing agreement for Ovation's topical / transdermal formulations for the state of Missouri. The Company's new licensee is MidWest Roots, LLC ("MidWest"); a company with a 65,000 square foot cannabis processing facility; one of the largest in M
CNW GroupOvation Science Signs License Agreement with Planet 13 for Its Topical / Transdermal Cannabis Products for Nevada
(CSE: OVAT) (OTCQB: OVATF) – Ovation Science Inc. ("Ovation" or the "Company"), with its proprietary topical and transdermal cannabis products powered by its patented skin delivery technology Invisicare®, today announced the signing of an exclusive licensing agreement with Planet 13 Holdings, Inc. (CSE: PLTH) (OTCQX: PLNHF) ("Planet 13"), a leading vertically-integrated multi-state cannabis company, for the rights to Ovation's topical / transdermal formulations for the state of Nevada.
